Health
AstraZeneca COVID-19 vaccine shows promise in elderly – Sydney Morning Herald
AstraZeneca and Oxford University researchers expect to release full late-stage trial results by Christmas.
Late-stage, or Phase III, trials are ongoing to confirm the findings, researchers said, and to test whether the vaccine protects against infection with SARS-CoV-2 in a broad range of people, including people with underlying health conditions.
Results of those trials should be known by Christmas, the Oxford Vaccine Group’s director Andrew Pollard said, adding it was too early to know whether and how well the vaccine works in actually preventing COVID-19.
“We haven’t quite got to that point yet. We’re…
-
Business20 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News17 hours agoWilliam Robinson dies aged 89
-
Business18 hours agoTop brokers name 3 ASX shares to buy today 27 August 2025
-
Business20 hours agoThis ASX 200 media stock is storming 7% higher to 52-week highs. Here’s why.